Login
$IAM
$14.41 +$0.15 (1.05%) Close
Iambic Therapeutics, Inc. is not yet matched to a CUSIP, so institutional (13F) holdings cannot be attributed to it. The sections below that come from its own filings still apply.

Who owns IAM?

Shares outstanding is not known for Iambic Therapeutics, Inc., so ownership cannot be shown as a share of the company.

Institutional ownership
—
Institutional holders
0
0 vs last qtr
Net shares bought
0
by institutions in Q2 2026
New / sold out
0 / 0
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

No 13F manager has reported this stock in the last 8 quarters.

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Iambic Therapeutics, Inc. in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for Iambic Therapeutics, Inc..

How patient are the owners?

No 13F manager reports holding IAM.

Super Investors

Investment managers reporting IAM on Form 13F
No 13F manager reports holding IAM yet.

Institutional Funds

Mutual funds and ETFs reporting IAM on Form N-PORT
No fund reports holding IAM yet.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
MF
Manby Frederick R
Insider
Shares
1.9M
% of company
—
Change vs last qtr
—
Held since
—
MT
Miller Thomas F.
Insider
Shares
1.4M
% of company
—
Change vs last qtr
—
Held since
—

6 more holders behind a free account

See every insider and 5%+ holder of Iambic Therapeutics, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support